|
|
|
 |
FDA Approval Activities for this Drug…
Tenex (guanfacine hydrochloride) Tablets, 1 and 2 mg A. H. Robbins NDA 19-032/ S16 & S17 | GUANFACINE HYDROCHLORIDE Tablet; 1MG BASE GUANFACINE HCL Amide | 074673 GUANFACINE HYDROCHLORIDE Tablet; 2MG BASE GUANFACINE HCL Amide | 019032 GUANFACINE HYDROCHLORIDE Tablet; 1MG BASE TENEX ESP 019032 GUANFACINE HYDROCHLORIDE Tablet; 2MG BASE TENEX ESP | 075109 GUANFACINE HYDROCHLORIDE Tablet; 1MG BASE GUANFACINE HCL Genpharm | 075109 GUANFACINE HYDROCHLORIDE Tablet; 2MG BASE GUANFACINE HCL Genpharm | | 074796 GUANFACINE HYDROCHLORIDE Tablet; 1MG BASE GUANFACINE HCL Mylan | 074796 GUANFACINE HYDROCHLORIDE Tablet; 2MG BASE GUANFACINE HCL Mylan | 074145 GUANFACINE HYDROCHLORIDE Tablet; 1MG BASE GUANFACINE HCL Watson | 074762 GUANFACINE HYDROCHLORIDE Tablet; 1MG BASE GUANFACINE HCL Watson | 074762 GUANFACINE HYDROCHLORIDE Tablet; 2MG BASE GUANFACINE HCL Watson | 074145 GUANFACINE HYDROCHLORIDE Tablet; 2MG BASE GUANFACINE HCL Watson | Intuniv (guanfacine) Extended-Release Tablets, Shire Pharmaceuticals, Inc., Approval | Intuniv (guanfacine hydrochloride) Extended-Release Tablets, Shire Development, Inc., Efficacy Supplement with Clinical Data to Support | Intuniv (guanfacine hydrochloride) Extended-Release Tablets, Shire Development, Inc., Labeling Revision
  
|